COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury
Author(s) -
José Manuel González-Rayas,
Ana Lilia RayasGómez,
José Juan GarcíaGonzález,
José Manuel González-Yáñez,
José A Hernández-Hernández,
R. López-Sánchez
Publication year - 2020
Publication title -
revista colombiana de cardiología
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 10
eISSN - 2357-3260
pISSN - 0120-5633
DOI - 10.1016/j.rccar.2020.04.005
Subject(s) - covid-19 , angiotensin receptor blockers , medicine , angiotensin converting enzyme , renin–angiotensin system , lung , angiotensin ii , ace inhibitor , pharmacology , peptidyl dipeptidase a , receptor , virology , disease , infectious disease (medical specialty) , outbreak , blood pressure
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom